CONCLUSION: Medical costs for RSV-associated hospitalisation of newborns are higher for children born premature or born during the RSV season. Prioritised targeting of those groups may facilitate a cost-efficient strategy for the national prevention program. PMID: 30266485 [PubMed - as supplied by publisher] (Source: Vaccine)
from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2NTcb3l
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.